Parkman Healthcare Partners »

ImmunoGen shares owned by Parkman Healthcare Partners

Quarter-by-quarter ownership of ImmunoGen shares owned by Parkman Healthcare Partners from 13F filings

Historical chart of Parkman Healthcare Partners investment in ImmunoGen

Tip: Access up to 7 years of quarterly data

All positions including ImmunoGen held by Parkman Healthcare Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ImmunoGen by Parkman Healthcare Partners

Quarter filed Position value Share count Share price at filing
2023-09-30 $11M 718k 15.87
2023-06-30 $16M 841k 18.87

More positions owned by Parkman Healthcare Partners

Boston Scientific Corporation (BSX)
United Therapeutics Corporation (UTHR)
Becton, Dickinson and (BDX)
Dex (DXCM)
Cooper Cos Com New
AmerisourceBergen (COR)
Tenet Healthcare Corp Com New (THC)
Hca Holdings (HCA)
Vaxcyte (PCVX)
ImmunoGen
Rxsight (RXST)
Schrodinger (SDGR)
Humana (HUM)
Keros Therapeutics (KROS)
Neurocrine Biosciences (NBIX)

View all positions for Parkman Healthcare Partners

Top funds holding ImmunoGen

Vanguard Group
RA Capital Management
Redmile Group
Henderson Group
Pentwater Capital Management
Fairmount Funds Management
Norges Bank Investment Management
Millennium Management
D. E. Shaw & Co
Balyasny Asset Management
Voloridge Investment Management
Boxer Capital
Maverick Capital
TIG Advisors
Tang Capital Management

View all funds holding ImmunoGen